Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial

Biological Psychiatry

Volumn 62, Issue 11, 2007, Pages 1208-1216

  O'Reardon, John P ^a   Solvason, H Brent ^b   Janicak, Philip G ^c   Sampson, Shirlene ^d   Isenberg, Keith E ^e   Nahas, Ziad ^j   McDonald, William M ^f   Avery, David ^g   Fitzgerald, Paul B ^h   Loo, Colleen ⁱ   Demitrack, Mark A ^k   George, Mark S ^j   Sackeim, Harold A ^l  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b STANFORD UNIVERSITY   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d Mayo Clinic   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^h MONASH UNIVERSITY   (Australia)

ⁱ UNIVERSITY OF NEW SOUTH WALES   (Australia)

^j MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^k Neuronetics   (United States)

^l NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

more..

Author keywords

Clinical trial; efficacy; major depression; safety; TMS

Indexed keywords

ADULT; AGED; ARTICLE; AUDIOMETRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NEUROSCIENCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AUDIOMETRY; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 33846271423     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2007.01.018     Document Type: Article

References (49)

1. Amassian V.E., Eberle L., Maccabee P.J., and Cracco R.Q. Modelling magnetic coil excitation of human cerebral cortex with a peripheral nerve immersed in a brain-shaped volume conductor: The significance of fiber bending in excitation. Electroencephalo Clin Neuro 85 (1992) 291-301
2. Anderson B., Mishory A., Nahas Z., Borckardt J.J., Yamanaka K., Rastogi K., and George M.S. Tolerability and safety of high daily doses of repetitive transcranial magnetic stimulation in healthy young men. J ECT 22 (2006) 49-53
3. Avery D.H., Holtzheimer III P.E., Fawaz W., Russo J., Neumaier J., Dunner D.L., et al. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant depression. Biol Psychiatry (2005) September 1 [Epub ahead of publication]
4. Bench C.J., Frackowiak R.S., and Dolan R.J. Changes in regional cerebral blood flow on recovery from depression. Psychol Med 25 (1995) 247-261
5. Bench C.J., Friston K.J., Brown R.G., Scott L.C., Frackowiak R.S., and Dolan R.J. The anatomy of melancholia-focal abnormalities of cerebral blood flow in major depression. Psychol Med 22 (1992) 607-615
6. Brody A.L., Saxena S., Stoessel P., Gillies L.A., Fairbanks L.A., Alborzian S., et al. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings [see comment]. Arch Gen Psychiatry 58 (2001) 631-640
7. Burt T., Lisanby S.H., and Sackeim H.A. Neuropsychiatric applications of transcranial magnetic stimulation: A meta analysis. Int J Neuropsychopharmacol 5 (2002) 73-103
8. Couturier J.L. Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: A systematic review and meta-analysis [see comment]. J Psychiatry Neurosci 30 (2005) 83-90
9. Fava M., Rush A.J., Wisniewski S.R., Nierenberg A.A., Alpert J.E., McGrath P.J., et al. A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: A STAR*D report. Am J Psychiatry 163 (2006) 1161-1172
10. Fitzgerald P.B., Brown T.L., Marston N.A., Daskalakis Z.J., De Castella A., and Kulkarni J. Transcranial magnetic stimulation in the treatment of depression: A double-blind, placebo-controlled trial. Arch Gen Psychiatry 60 (2003) 1002-1008
11. George M.S., Ketter T.A., Parekh P.I., Horwitz B., Herscovitch P., and Post R.M. Brain activity during transient sadness and happiness in healthy women. Am J Psychiatry 152 (1995) 341-351
12. George M.S., Ketter T.A., and Post R.M. SPECT and PET imaging in mood disorders. J Clin Psychiatry 54 (1993) 6-13
13. George M.S., Ketter T.A., and Post R.M. SPECT and PET imaging in mood disorders. J Clin Psychiatry 54 suppl (1993) 6-13
14. George M.S., Nahas Z., Molloy M., Speer A.M., Oliver N.C., Li X.B., et al. A controlled trial of daily left prefrontal cortex TMS for treating depression [see comment]. Biol Psychiatry 48 (2000) 962-970
15. George M.S., and Wassermann E.M. Rapid-rate transcranial magnetic stimulation and ECT. Convuls Ther 10 (1994) 251-254 discussion 255-258
16. George M.S., Wassermann E.M., Kimbrell T.A., Little J.T., Williams W.E., Danielson A.L., et al. Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: A placebo-controlled crossover trial. Am J Psychiatry 154 (1997) 1752-1756
17. George M.S., Wassermann E.M., Williams W.A., Callahan A., Ketter T.A., Basser P., et al. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport 6 (1995) 1853-1856
18. Greden J.F. The burden of recurrent depression: Causes, consequences, and future prospects. J Clin Psychiatry 22 (2001) 5-9
19. Herwig U., Satrapi P., and Schonfeldt-Lecuona C. Using the international 10-20 EEG system for positioning of transcranial magnetic stimulation. Brain Topogr 16 (2003) 95-99
20. Herwig U., Schonfeldt-Lecuona C., Wunderlich A.P., von Tiesenhausen C., Thielscher A., Walter H., and Spitzer M. The navigation of transcranial magnetic stimulation. Psychiatry Res 108 (2001) 123-131
21. Khan A., Warner H.A., and Brown W.A. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database [see comment]. Arch Gene Psychiatry 57 (2000) 311-317
22. Kimbrell T.A., Ketter T.A., George M.S., Little J.T., Benson B.E., Willis M.W., et al. Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biol Psychiatry 51 (2002) 237-252
23. Klein E., Kreinin I., Chistyakov A., Koren D., Mecz L., Marmur S., et al. Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: A double-blind controlled study [see comment]. Arch Gen Psychiatry 56 (1999) 315-320
24. Kozel A., and George M. Meta-analysis of left prefrontal repetitive transcranial magnetic stimulation (rTMS) to treat depression. J Psychiatr Pract 8 (2002) 270-275
25. Kraemer H.C., and Kupfer D.J. Size of treatment effects and their importance to clinical research and practice. Biological Psychiatry 59 (2006) 990-996
26. Loo C., Mitchell P., Sachdev P., McDarmont B., Parker G., and Gandevia S. Double-blind controlled investigation of transcranial magnetic stimulation for the treatment of resistant major depression. Am J Psychiatry 156 (1999) 946-948
27. Loo C., Sachdev P., Elsayed H., McDarmot B., Mitchell P., Wilkonson M., et al. Effects of a 2- to 4-week course of repetitive transcranial magnetic stimulation (rTMS) on neuropsychologic functioning, electroencephalogram, and auditory threshold in depressed patients. Biol Psychiatry 49 (2001) 615-623
28. Martin J.L., Barbanoj M.J., Schlaepfer T.E., Clos S., Perez V., Kulisevsky J., and Gironell A. Transcranial magnetic stimulation for treating depression. Cochrane Database of Systematic Reviews 2 (2002) CD003493
29. Mayberg H.S. Modulating limbic-cortical circuits in depression: Targets of antidepressant treatments. Sem Clin Neuropsychiatry 7 (2002) 255-268
30. Mayberg H.S. Positron emission tomography imaging in depression: a neural systems perspective. Neuroimag Clin North Am 13 (2003) 805-815
31. McNamara B., Ray J.L., Arthurs O.J., and Boniface S. Transcranial magnetic stimulation for depression and other psychiatric disorders [see comment]. Psychol Med 31 (2001) 1141-1146
32. Murray C., and Lopez A. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020 (1996), Harcourt University Press, Cambridge, MA
33. Nobler M.S., Oquendo M.A., Kegeles L.S., et al. Decreased regional brain metabolism after ECT. Am J Psychiatry 158 (2001) 305-308
34. Pascual-Leone A., Rubio B., Pallardo F., and Catala M.D. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression [see comment]. Lancet 348 (1996) 233-237
35. Pridmore S., Fernandes Filho J.A., Nahas Z., Liberatos C., and George M.S. Motor threshold in transcranial magnetic stimulation: A comparison of a neurophysiological method and a visualization of movement method. J ECT 14 (1998) 25-27
36. Prudic J., Haskett R.F., Mulsant B., Malone K.M., Pettinati H.M., Stephens S., et al. Resistance to antidepressant medications and short-term clinical response to ECT [see comment]. Am J Psychiatry 153 (1996) 985-992
37. Prudic J., Sackeim H.A., and Devanand D.P. Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res 31 (1990) 287-296
38. Robinson R.G., Boston J.D., Starkstein S.E., and Price T.R. Comparison of mania and depression after brain injury: Causal factors. Am J Psychiatry 145 (1988) 172-178
39. Robinson R.G., Kubos K.L., Starr L.B., Rao K., and Price T.R. Mood disorders in stroke patients: Importance of location of lesion. Brain 107 (1984) 81-93
40. Roth B.J., Cohen L.G., and Hallett M. the electric field induced during magnetic stimulation. In: Lecy W.J., Cracco R.Q., Barker A.T., and Rothwell J. (Eds). Magnetic Motor Stimulation: Basic Principles and Clinical Experience (1991), Elsevier Science, Amsterdam 268-278 (EEG Suppl. 43)
41. Roth B.J., Saypol J.M., Hallett M., and Cohen L.G. A theoretical calculation of the electric field induced in the cortex during magnetic stimulation. Electroencephalo Clin Neuro 81 (1991) 47-56
42. Rush A.J., Trivedi M.H., Wisniewski S.R., Stewart J.W., Nierenberg A.A., Thase M.E., et al. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. New Engl J Med 354 (2006) 1231-1242
43. Sackeim H.A. Functional brain circuits in major depression and remission [comment]. Arch Gen Psychiatry 58 (2001) 649-650
44. Sackeim H.A. The definition and meaning of treatment-resistant depression. J Clin Psychiatry 16 (2001) 10-17
45. Sackeim H.A., Prudic J., Devanand D.P., Decina P., Kerr B., and Malitz S. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 10 (1990) 96-104
46. Sackeim H.A., Rush A.J., George M.S., Marangell L.B., Husain M.M., Nahas Z., et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: Efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 25 (2001) 713-728
47. Thase M.E., Haight B.R., Richard N., Rockett C.B., Mitton M., Modell J.G., et al. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. J Clin Psychiatry 66 (2005) 974-981
48. Trivedi M.H., Rush A.J., Wisniewski S.R., Nierenberg A.A., Warden D., Ritz L., et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. Am J Psychiatry 163 (2006) 28-40
49. Wassermann E.M. Risk and safety of repetitive transcranial magnetic stimulation: Report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr Clin Neurophysiol 108 (1998) 1-16